Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q0175. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
15
Median % of Medicare
--
Rate range
$0.08 - $1.79
Q0175 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arizona | $0.47 | -- | -- | 2026 |
| Idaho | $0.47 | -- | Not required | 2025 |
| Illinois | $0.19 | -- | -- | 2026 |
| Indiana | $0.08 | -- | -- | 2025 |
| Massachusetts | $1.72 | -- | -- | 2026 |
| Minnesota | $0.30 | -- | -- | 2026 |
| Montana | $0.64 | -- | -- | 2026 |
| New Hampshire | $0.30 | -- | Not required | 2026 |
| New Jersey | $0.78 | -- | Not required | 2026 |
| New Mexico | $0.59 | -- | -- | 2025 |
| Oklahoma | $0.30 | -- | -- | 2026 |
| Texas | $1.79* | -- | -- | 2022 |
| Virginia | $0.66 | -- | -- | 2010 |
| Washington | $0.93 | -- | -- | 2026 |
| Wisconsin | $0.55 | -- | -- | 2011 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 52 codes from Q0035 to Q0506 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q0175?
15 state Medicaid programs publish a fee-for-service rate for Q0175 (perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen), ranging from $0.08 in Indiana to $1.79 in Texas. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q0175?
Texas publishes the highest Medicaid rate for Q0175 at $1.79. Indiana publishes the lowest at $0.08.
Does Q0175 require prior authorization under Medicaid?
No publishing state flags Q0175 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.